iaslc
Entity, reached from Hormuz.
- Evidence
- 26 documents · 6 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 12 Sept 2026, last seen 6 Oct 2026
- Measured
- 8% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- The ASCO Post · 2026-10-06 · Extensive-Stage SCLC Subcutaneous Tarlatamab (opens the source in a new tab)
- The ASCO Post · 2026-10-05 · Relapsed or Refractory SCLC Phase I Study of Novel CAR T-Cell Therapy (opens the source in a new tab)
- The ASCO Post · 2026-10-05 · Metastatic PD-L1–High NSCLC Sacituzumab Govitecan/Pembrolizumab (opens the source in a new tab)
- The ASCO Post · 2026-10-02 · Advanced Lung Cancer Pumitamig Plus Elfetabart Drozuntecan (opens the source in a new tab)
- The ASCO Post · 2026-09-30 · Targeting B7-H3 in Second-Line SCLC Treatment Novel ADCs (opens the source in a new tab)
- The ASCO Post · 2026-09-29 · Mobile Lung CT Screening in Resource-Limited Settings BRELT3 (opens the source in a new tab)
- The ASCO Post · 2026-09-24 · SCLC Tarlatamab Extended-Interval Dosing Regimens (opens the source in a new tab)
- The ASCO Post · 2026-09-22 · Metastatic HER2-Mutant NSCLC First-Line T-DXd (opens the source in a new tab)
- Inside Precision Medicine · 2026-09-17 · IASLC Tumor Budding Grade Identifies High-Risk Lung Squamous Cell Carcinoma Patients (opens the source in a new tab)
- PR Newswire · 2026-09-12 · International Association for the Study of Lung Cancer Launches Complimentary IASLC Full Membership for Eligible Countries to Expand Worldwide Participation in Thoracic Onc… (opens the source in a new tab)
2 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with lung cancer (26 documents)seen together
- co-mentioned with wclc (24 documents)seen together
- co-mentioned with egfr (15 documents)seen together
- co-mentioned with cancer center (14 documents)seen together
- co-mentioned with international association (13 documents)seen together
- co-mentioned with egfr-mutated (12 documents)seen together
- co-mentioned with iiib (12 documents)seen together
- co-mentioned with dana-farber cancer institute (11 documents)seen together
- co-mentioned with her2-mutant (10 documents)seen together
- co-mentioned with her3 (10 documents)seen together